A Phase 4 interventional study of Mepivacaine and Saline in Tourniquet Hypertension, Intraoperative Hypertension and Total Ankle Arthroplasty, sponsored by Duke University. Recruiting at 1 site in United States. Open to participants aged 18 Years to 75 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-03-23.
Sponsored by Duke University · Phase 4, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 46 studies in Hypertension by Duke University — 8 open to participants now, 9 under way, none of them phase 3. Hypertension · Duke University.
Among the 46 studies in Hypertension by Duke University, this one is the 29th largest by planned enrollment of the 37 interventional ones that give a count, is one of 2 that started in 2021, is one of 2 in phase 4, and was the 32nd registered.
6,128 studies on the registry are indexed under Hypertension; 907 are open to participants now.
Browse Hypertension studies →8 of the 46 studies in Hypertension by Duke University are open now, in 2 countries. Recruiting first, the newest first:
Duke University · Sites in United States
Ages 18+
Duke University · Sites in United States
Ages 18+
Duke University · Sites in United States
Ages 6–14 · Healthy volunteers
Duke University · Sites in United States, Canada
Ages 0–20 · Healthy volunteers
Duke University · Sites in United States
Ages 12–17 · Healthy volunteers
By country, each count listing its studies:
Of the 552 Hypertension studies recruiting now, 260 (47%) set no upper age limit and 198 (36%) stop at 75 or younger; 40 take children under 18; 136 take healthy volunteers.
This study: 18 Years to 75 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
46 studies; the count open now beside each. This study's row is marked.
First in 2000; this study’s year is marked. 2 started in 2021.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 40 is below the median of 100 across 4,585 interventional studies indexed under Hypertension.
Median enrollment 140 across the 37 interventional studies, 1,000 across the 8 observational. Of the 36 that completed or were terminated, 9 (25%) have results posted.
This tab as a report to print or save as PDF → With an account.
Duke University is the lead sponsor of 2,064 studies on the registry; 271 are open to participants now.
Of its 204 completed or terminated interventional studies of FDA-regulated products, 170 (83%) have results posted.
6 of the studies in Hypertension by Duke University that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT04278404Duke UniversityPharmacokinetics, Pharmacodynamics, and Safety Profile of Understudied Drugs Administered to Children Per Standard of Care (POPS) | 2026-11 |
| NCT05459077Duke UniversityAddressing Barriers to Anti-hypertensive Medication Adherence Among PLWH Who Have Achieved Viral Suppression | 2026-12-30 |
| NCT05760898Duke UniversityImproving Hypertension Control in Rheumatoid Arthritis | 2026-12-31 |
| NCT04454203Duke UniversityFemoral Peri-arterial Local Anesthetic Injection Via Peri-arterial Perineural Catheter Reverses Tourniquet Associated Ischemic Hypertension | 2027-02-01 |
| NCT06595251Duke UniversityCommunity Park-Based Programs for Health Promotion: Fit2Play Prospective Cohort Study | 2027-05-17 |
Add all 6 to your calendar (.ics) → With an account.
Among the 46 studies in Hypertension by Duke University, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The goal of this prospective randomized double-blind study is to determine if an ultrasound guided peri-arterial injection of local anesthetic (LA) superomedially the femoral artery via peripheral nerve catheter reverses ischemic hypertension associated with prolonged lower extremity tourniquet time.
This is a research study to find out if injection of numbing medication by the large artery going down your leg will improve high blood pressure caused by the tourniquet.
Depending on whether you enroll in this study, you may receive an injection of local anesthetic (numbing medication) or saline (salt water) by your femoral artery (the large artery going down your leg). This is to see how this injection impacts your blood pressure during surgery as the surgeons use a tourniquet (device that squeezes your leg) to help decrease the bleeding during surgery. Oftentimes the tourniquet causes your blood pressure to go up, but the numbing medication may help return your blood pressure close to its normal level. The rest of your anesthesia care, including other nerve blocks and general anesthetic, will be the same as it would be without participating in the study. You will be enrolled in this study for 24 hours.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Patients that will be included in the study are English speaking 18-75 year old ASA 1-3 patients undergoing total ankle arthroplasty.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Clinically significant
Judged by the study doctor to matter for your health or for the study. It is a doctor’s decision, so ask the study team if you are unsure whether something counts.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Infiltration of local anesthetic (mepivacaine) above and beside the femoral artery through a perineural catheter.
Drug: Mepivacaine · Procedure: Perifemoral Injection of Local Anesthetic
Infiltration of salt water (saline) above and beside the femoral artery through a perineural catheter.
Drug: Saline · Procedure: Perifemoral Injection of Local Anesthetic
An infiltration of mepivacaine superomedially to the femoral artery via perineural catheter.
Also known as: Carbocaine
An infiltration of saline superomedially to the femoral artery via perineural catheter.
Also known as: Salt water placebo
Infiltration of mepivacaine superomedially to the formal artery via perineural catheter in an effort to numb the nerves that contribute to tourniquet hypertension intraoperatively.
Also known as: Femoral Periarterial Injection
Infiltration of saline superomedially to the formal artery via perineural catheter that should NOT numb the nerves that contribute to tourniquet hypertension intraoperatively.
Also known as: Femoral Periarterial Injection
Change in tourniquet hypertension as measured by systolic blood pressure
Infiltrating study drug to reverse intraoperative tourniquet hypertension
Time frame: From time of injection to 30 minutes after injection
Pain Scores (NRS11)
The 11-point numeric scale ranges from '0' representing one pain extreme (e.g. "no pain") to '10' representing the other pain extreme (e.g. "pain as bad as you can imagine" or "worst pain imaginable")
Time frame: Perioperative start until 2 hours after admission to PACU
Opioid consumption
Perioperative opioid consumption as measured in oral morphine equivalents (OMEs)
Time frame: Perioperative start until 2 hours after admission to PACU
Quadriceps motor function
Gross quadriceps motor function as measured by leg extension
Time frame: 1 hour after extubation
Plan to share: No — Individual participant data will not be shared; patients will be deidentified and no personal information or medical records used.
No publications or documents are linked to this record.
Started Feb 2021 (actual). Primary completion is estimated for Feb 2027, 71 months after the start.
Of 126 non-industry phase 4 interventional studies under Hypertension, half reached primary completion within 36 months of starting (the median), counting those still running; a quarter within 15 and three quarters within 55. This study's planned 71 months is above that.
Counting every sponsor, half of 161 studies reached it within 31 months; a quarter within 16 and three quarters within 52.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Studies of the drug tested here: Mepivacaine